Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Thoracic 1Other neoplasm 1Dermatologic 1CNS 1

Conditions

Breast Neoplasms 2Radiation Fibrosis Syndrome 1Peripheral Nervous System Diseases 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 183Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 93Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Losartan × Breast × Clear all
NCT05607017 2026-04-06

Losartan in Prevention of Radiation-Induced Heart Failure

Massachusetts General Hospital

Phase EARLY_PHASE1 Completed
5 enrolled
Breast

Radiation Fibrosis Syndrome, Breast Neoplasms

NCT06135493 2025-04-24

Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients

Future University in Egypt

Phase 2 Completed
84 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡